Novo Nordisk Hit By Cyberattack, Trial Data Stolen
Danish pharmaceutical giant Novo Nordisk disclosed a cyberattack resulting in the theft of sensitive clinical trial data. The breach occurred as the UK regulatory body approved the oral version of Wegovy, raising concerns about intellectual property theft and potential competitive intelligence gathe